Color on UBS Upgrade of Motorola (MOT): Estimates Still Too Conservative
Get Alerts MOT Hot Sheet
Price: $9.11 --0%
Rating Summary:
4 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
More color on UBS's earlier upgrade of Motorola (NYSE: MOT):
UBS upgrades Motorola from Neutral to Buy, also raising its price target from $7.50 to $11.50.
The firm believes that Street estimates on Motorola remain too conservative, even in light of consistent gains since March. UBS specifically calls analysts FY10 profit estimate for Motorola's mobile devices business as underestimated, saying the company is now relying more on higher margin smartphones. And with one more phone to be unveiled this year, and several more in early 2010, UBS believes the news flow at Motorola should be positive over the near-term.
UBS lifted its FY10 EPS estimate from $0.31 to $0.34, which compares to the Street estimate of $0.26.
Shares of Motorola are up about 1.5% to $8.81 on the back of the upgrade. UBS's new price target represents potential upside of about 30.5% from current levels.
UBS upgrades Motorola from Neutral to Buy, also raising its price target from $7.50 to $11.50.
The firm believes that Street estimates on Motorola remain too conservative, even in light of consistent gains since March. UBS specifically calls analysts FY10 profit estimate for Motorola's mobile devices business as underestimated, saying the company is now relying more on higher margin smartphones. And with one more phone to be unveiled this year, and several more in early 2010, UBS believes the news flow at Motorola should be positive over the near-term.
UBS lifted its FY10 EPS estimate from $0.31 to $0.34, which compares to the Street estimate of $0.26.
Shares of Motorola are up about 1.5% to $8.81 on the back of the upgrade. UBS's new price target represents potential upside of about 30.5% from current levels.
You May Also Be Interested In
- enVVeno Medical (NVNO) files $100M mixed shelf
- Andersen closes secondary offering of 4.9M shares at $44 each
Create E-mail Alert Related Categories
Insiders' Blog, UpgradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share